Skip to main content
Clinical Trials/NCT01331187
NCT01331187CompletedNot Applicable

Influence on Diagnostics and Inpatient Workflow of Routinely Adding Ultrasound Screening by Pocket-size Ultrasound in a Medical Department

Helse Nord-Trøndelag HF2 sites in 1 country600 target enrollmentStarted: April 1, 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
600
Locations
2
Primary Endpoint
Time to definitive diagnosis

Study Overview

Brief Summary

Ultrasound (US) is widely used as a diagnostic tool in a hospital setting. In a medical department, diagnosis like heart failure or most kinds of heart diseases, hypervolemia, hypovolemia, pleural effusion, pericardial effusion, ascites, diseases in the gall bladder/bile tract, urine tract and venous thrombosis are common. US is the key diagnostic tool in these diagnosis, and on early diagnosis is crucial with respect to the patients well-being and inpatients workflow.

  1. The aim is to study the clinical use of pocket-size US as a screening diagnostic tool in an medical department with respect to inpatients workflow and diagnostics.

Method: Patients admitted (in certain preset periods) to Department of medicine will be randomized to routinely adding an ultrasound examination with pocket-size device by residents on call. Time to definitive diagnosis, time to definitive treatment and time to discard will be recorded. US findings will be validated against standard echocardiography, or standard US/CT/MRI performed at the Radiological department.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
16 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients admitted to Dep. of Medicine at Levanger Hospital

Exclusion Criteria

  • Not able to give informed consent

Outcomes

Primary Outcomes

Time to definitive diagnosis

Time Frame: 3 months

Time from admittance to definitive diagnosis

Secondary Outcomes

  • Time to definitive treatment(3 months)
  • Time to discharge(3 months)
  • Test-retest reproducibility(3 months)
  • Diagnostic outcome of additional ultrasound examination according to educational level of the performer(3 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Influence of Routinely Adding Ultrasound... | Clinical Trial